Literature DB >> 16114793

Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment.

E Zuliani1, H Zwahlen, F Gilliet, C Marone.   

Abstract

Drug rash with eosinophilia and systemic symptoms or DRESS syndrome is a distinct severe drug-induced hypersensitivity reaction characterized by skin rash, fever, eosinophilia and visceral involvement. The latter leads to a 10% mortality rate, with interstitial nephritis occurring in about 10% of the cases. The outcome is usually favorable after withdrawal of drug therapy; systemic corticosteroid therapy may hasten the recovery, although there are no data from prospective, randomized trials evaluating the efficacy of this approach. Administration of other immunosuppressive agents (cyclophosphamide, cyclosporine) has also been suggested. We report on a patient with vancomycin-induced DRESS syndrome with acute interstitial nephritis and hepatitis. There was no improvement after withdrawal of the offending agent and empiric corticosteroid use. After tapering the steroids, a five-day course of cyclosporine was followed by quick resolution of the skin rash and recovery of renal function. Cyclosporine could represent a treatment option in cases of severe visceral involvement such as persistent renal insufficiency that do not improve after discontinuation of the offending agent and administration of high doses of steroids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114793     DOI: 10.5414/cnp64155

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  22 in total

1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

2.  Immune-mediated reactions to vancomycin: A systematic case review and analysis.

Authors:  Jasmit S Minhas; Paige G Wickner; Aidan A Long; Aleena Banerji; Kimberly G Blumenthal
Journal:  Ann Allergy Asthma Immunol       Date:  2016-05-04       Impact factor: 6.347

3.  DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin.

Authors:  Paloma O'Meara; Rozita Borici-Mazi; A Ross Morton; Anne K Ellis
Journal:  Allergy Asthma Clin Immunol       Date:  2011-10-03       Impact factor: 3.406

4.  Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome?

Authors:  Müberra Devrim Güner; Semra Tuncbilek; Burak Akan; Aysun Caliskan-Kartal
Journal:  BMJ Case Rep       Date:  2015-05-28

5.  Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics.

Authors:  Kimberly G Blumenthal; Ilan Youngster; Dustin J Rabideau; Robert A Parker; Karen S Manning; Rochelle P Walensky; Sandra B Nelson
Journal:  J Allergy Clin Immunol       Date:  2015-05-14       Impact factor: 10.793

6.  Enigma: infection or allergy? Vancomycin-induced DRESS syndrome with dialysis-dependent renal failure and cardiac arrest.

Authors:  Philip Simon Webb; Abdallah Al-Mohammad
Journal:  BMJ Case Rep       Date:  2016-08-29

Review 7.  Review of vancomycin-induced renal toxicity: an update.

Authors:  Oluwatoyin Bamgbola
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-30       Impact factor: 3.565

8.  Vancomycin-associated spontaneous cutaneous adverse drug reactions.

Authors:  So-Yeon An; Eui-Kyung Hwang; Joo-Hee Kim; Jeong-Eun Kim; Hyun-Jung Jin; Sun-Min Jin; Jin-Ok Kyun; Young-Hee Lee; Hae-Sim Park; Young Wha Choi; Seung-Kwan Lim; Young-Min Ye
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-19       Impact factor: 5.764

Review 9.  Acute tubulointerstitial nephritis.

Authors:  Tim Ulinski; Anne-Laure Sellier-Leclerc; Elena Tudorache; Albert Bensman; Bilal Aoun
Journal:  Pediatr Nephrol       Date:  2011-06-03       Impact factor: 3.651

Review 10.  Current Perspectives on Severe Drug Eruption.

Authors:  Jingzhan Zhang; Zixian Lei; Chen Xu; Juan Zhao; Xiaojing Kang
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-17       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.